Sofosbuvir Not Yet Recruiting Phase 2 Trials for Indolent Lymphoma Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03261349Antiviral Agent HARVONIĀ® for the Treatment of HCV-associated Indolent B-Cell Lymphoma